[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].
about
[Akkermansia muciniphila: a novel target controlling obesity, type 2 diabetes and inflammation?].[Gut microbiota and digestion of polysaccharides].[DOHaD: long-term impact of perinatal diseases (IUGR and prematurity)].[Microbiota and representations of the human body].The impact of probiotics' administration on glycemic control, body composition, gut microbiome, mitochondria, and other hormonal signals in adolescents with prediabetes - A randomized, controlled trial study protocol.
P2860
[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@ast
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@en
type
label
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@ast
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@en
prefLabel
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@ast
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@en
P2093
P2860
P356
P1433
P1476
[Intestinal microbiota and nov ...... atment of metabolic diseases].
@en
P2093
Chantal Chabo
Jacques Amar
Rémy Burcelin
Vincent Blasco-Baque
P2860
P304
P356
10.1051/MEDSCI/2013298021
P407
P50
P577
2013-08-01T00:00:00Z